These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
338 related articles for article (PubMed ID: 27468184)
1. Exploring the role of molecular biomarkers as a potential weapon against gastric cancer: A review of the literature. Matboli M; El-Nakeep S; Hossam N; Habieb A; Azazy AE; Ebrahim AE; Nagy Z; Abdel-Rahman O World J Gastroenterol; 2016 Jul; 22(26):5896-908. PubMed ID: 27468184 [TBL] [Abstract][Full Text] [Related]
2. Targeted therapies in metastatic gastric cancer: Current knowledge and future perspectives. Pellino A; Riello E; Nappo F; Brignola S; Murgioni S; Djaballah SA; Lonardi S; Zagonel V; Rugge M; Loupakis F; Fassan M World J Gastroenterol; 2019 Oct; 25(38):5773-5788. PubMed ID: 31636471 [TBL] [Abstract][Full Text] [Related]
3. Identification of targeted therapy options for gastric adenocarcinoma by comprehensive analysis of genomic data. Hescheler DA; Plum PS; Zander T; Quaas A; Korenkov M; Gassa A; Michel M; Bruns CJ; Alakus H Gastric Cancer; 2020 Jul; 23(4):627-638. PubMed ID: 32107691 [TBL] [Abstract][Full Text] [Related]
4. Predictive biomarkers for targeted and cytotoxic agents in gastric cancer for personalized medicine. Wang S; Yuan L Biosci Trends; 2016 Jul; 10(3):171-80. PubMed ID: 27251446 [TBL] [Abstract][Full Text] [Related]
5. Personalized medicine in gastric cancer: Where are we and where are we going? Jácome AA; Coutinho AK; Lima EM; Andrade AC; Dos Santos JS World J Gastroenterol; 2016 Jan; 22(3):1160-71. PubMed ID: 26811654 [TBL] [Abstract][Full Text] [Related]
6. Targeting the PI3K/Akt signaling pathway in gastric carcinoma: A reality for personalized medicine? Singh SS; Yap WN; Arfuso F; Kar S; Wang C; Cai W; Dharmarajan AM; Sethi G; Kumar AP World J Gastroenterol; 2015 Nov; 21(43):12261-73. PubMed ID: 26604635 [TBL] [Abstract][Full Text] [Related]
7. Targeted therapy for gastric adenocarcinoma. Almhanna K Adv Pharmacol; 2012; 65():437-70. PubMed ID: 22959034 [TBL] [Abstract][Full Text] [Related]
8. Recent advances in the molecular diagnostics of gastric cancer. Kanda M; Kodera Y World J Gastroenterol; 2015 Sep; 21(34):9838-52. PubMed ID: 26379391 [TBL] [Abstract][Full Text] [Related]
9. How prognostic and predictive biomarkers are transforming our understanding and management of advanced gastric cancer. Kim C; Mulder K; Spratlin J Oncologist; 2014 Oct; 19(10):1046-55. PubMed ID: 25142842 [TBL] [Abstract][Full Text] [Related]
11. The low-abundance transcriptome reveals novel biomarkers, specific intracellular pathways and targetable genes associated with advanced gastric cancer. Bizama C; Benavente F; Salvatierra E; Gutiérrez-Moraga A; Espinoza JA; Fernández EA; Roa I; Mazzolini G; Sagredo EA; Gidekel M; Podhajcer OL Int J Cancer; 2014 Feb; 134(4):755-64. PubMed ID: 23907728 [TBL] [Abstract][Full Text] [Related]
12. The relevance of gastric cancer biomarkers in prognosis and pre- and post- chemotherapy in clinical practice. Abbas M; Habib M; Naveed M; Karthik K; Dhama K; Shi M; Dingding C Biomed Pharmacother; 2017 Nov; 95():1082-1090. PubMed ID: 28922727 [TBL] [Abstract][Full Text] [Related]
13. Integrated epigenomics identifies BMP4 as a modulator of cisplatin sensitivity in gastric cancer. Ivanova T; Zouridis H; Wu Y; Cheng LL; Tan IB; Gopalakrishnan V; Ooi CH; Lee J; Qin L; Wu J; Lee M; Rha SY; Huang D; Liem N; Yeoh KG; Yong WP; Teh BT; Tan P Gut; 2013 Jan; 62(1):22-33. PubMed ID: 22535375 [TBL] [Abstract][Full Text] [Related]
14. Low expression of DLC1 is predictive of poor therapeutic efficiency of fluoropyrimidine and oxaliplatin as adjuvant chemotherapy in gastric cancer. Su Y; Lin L; Zhang J; Jiang Y; Pan C; Sun L; Duan J; Liao W Mol Med Rep; 2015 Oct; 12(4):5771-9. PubMed ID: 26239822 [TBL] [Abstract][Full Text] [Related]
15. Recent updates of precision therapy for gastric cancer: Towards optimal tailored management. Joo MK; Park JJ; Chun HJ World J Gastroenterol; 2016 May; 22(19):4638-50. PubMed ID: 27217696 [TBL] [Abstract][Full Text] [Related]
16. [GRP78 expression in gastric cancer and its clinical significance]. Yang L; Yang SY; Ji JM; Cao YF; Ji CF; Ji JF; Xu WW; Wang JH Zhonghua Zhong Liu Za Zhi; 2013 Nov; 35(11):837-42. PubMed ID: 24447482 [TBL] [Abstract][Full Text] [Related]
17. The Expression of Melanoma-Associated Antigen D2 Both in Surgically Resected and Serum Samples Serves as Clinically Relevant Biomarker of Gastric Cancer Progression. Kanda M; Nomoto S; Oya H; Takami H; Shimizu D; Hibino S; Hashimoto R; Kobayashi D; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y Ann Surg Oncol; 2016 Feb; 23 Suppl 2():S214-21. PubMed ID: 25743330 [TBL] [Abstract][Full Text] [Related]
18. Molecular classification of gastric cancer: Towards a pathway-driven targeted therapy. Riquelme I; Saavedra K; Espinoza JA; Weber H; García P; Nervi B; Garrido M; Corvalán AH; Roa JC; Bizama C Oncotarget; 2015 Sep; 6(28):24750-79. PubMed ID: 26267324 [TBL] [Abstract][Full Text] [Related]
19. Review of recent molecular landscape knowledge of gastric cancer. Shimizu D; Kanda M; Kodera Y Histol Histopathol; 2018 Jan; 33(1):11-26. PubMed ID: 28447336 [TBL] [Abstract][Full Text] [Related]
20. Methylation-mediated gene silencing as biomarkers of gastric cancer: a review. Nakamura J; Tanaka T; Kitajima Y; Noshiro H; Miyazaki K World J Gastroenterol; 2014 Sep; 20(34):11991-2006. PubMed ID: 25232236 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]